Wesfarmers shares in 2025: What to expect, growth forecasts

Retail is in for an interesting year in 2025.

| More on:

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the 'five best ASX stocks' for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now...

See The 5 Stocks *Returns as of 6 March 2025

Young couple at the counter of a hardware store.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Wesfarmers Ltd (ASX: WES) shares have climbed a hefty 30% so far this year, albeit with some ups and downs along the way.

After retreating from August highs of $77.20 apiece, shares have lifted almost 9% in the past month to trade at $74.36 at the time of writing.

Looking ahead, can this retail conglomerate use its diversified portfolio to drive growth in 2025? Let's see what the experts think.

Created with Highcharts 11.4.3Wesfarmers PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

Challenges and opportunities for Wesfarmers shares

The outlook for Wesfarmers shares in 2025 will be shaped by the company's specific business lines and the economic landscape.

Analysts remain divided on the consumer discretionary stock. Goldman Sachs rates it a hold, whereas the consensus rating by brokers is a sell, according to CommSec.

Goldman's concerns are on Wesfarmers' current valuation and potentially declining margins in Kmart.

But the broker also noted the earnings power of Bunnings, along with its other growth avenues, such as healthcare and lithium.

We continue to expect Bunnings to be trading strongly and gaining share in both DIY and Trade despite a more challenging operating backdrop, and we see multiple growth options for the business as previously illustrated in our deep dive note, including Lithium and WES Health as well as Bunnings Marketplace and Retail Media.

But Wesfarmers shares are trading in line with Goldman's range of valuation estimates at a price-to-earnings (P/E) ratio of 33x, leaving the broker neutral on valuation.

It values the stock at $69.50 apiece, citing the added downside risks from lower consumer spending and a weaker retail outlook.

And Goldman may be onto something there as well.

According to the Creditor Watch 2025 Business and Economic Outlook, the retailer could "remain under some pressure" next year.

The past 12 months although prices and turnover remain much higher than before COVID. Forward orders have declined, as has profitability and business conditions.

This reflects a combination of a higher cost of living, higher interest rates and likely the pull-forward of some demand during COVID lockdowns.

Discretionary spending volumes have even declined a little, despite very strong population growth, as consumers have tightened their wallets under the aforementioned pressures.

These issues could potentially clamp discretionary spending for consumers in Australia. This could impact Wesfarmers' retail brands, including Kmart and Target, according to PAC Partners.

But at the same time, Wesfarmers is a diversified conglomerate with many lines of business.

These include non-discretionary segments, such as its healthcare portfolio and its investments in lithium.

Core business is sound

Wesfarmers shares have been pushed higher in 2024 from performance in its key brands, including Bunnings.

The home improvements warehouse continues to shine with a return on capital of 69% in FY24. Analysts expect Bunnings to remain a growth driver for the business.

Its healthcare division includes the Priceline Pharmacy and Soul Pattinson Chemist brands and isn't overly sensitive to the business cycle.

And this could be a long-term driver for the company based on broad healthcare trends.

Fidelity International says that healthcare is a "notable structural driver" due to the ageing population. It estimates that the over-65 population will double by 2050.

Meanwhile, Wesfarmers has also entered the lithium market through its stake in Covalent Lithium, which provides interesting exposure to the battery materials sector.

Wesfarmers CEO Rob Scott says the company is focused on getting its hydroxide plant up and running by mid-2025.

Wesfarmers has forecast dividends of $1.98 per share for FY25, which will grow to $2.36 by FY26 at a compound annual growth rate (CAGR) of 9.2%.

Consensus estimates also project earnings to grow at a CAGR of 9.9% over this time as well.

Foolish takeaway

Like many in the retail space, Wesfarmers shares face a challenging year ahead. High interest rates and cost-of-living pressures are weighing on consumer spending.

However, its diversified portfolio and major investments in healthcare and lithium also provide the bedrock for a running stream of earnings growth.

Even with the challenges above, consensus estimates still project the business to grow its earnings and dividends at more than 9% per year to FY26.

Wesfarmers shares have climbed 38% in the past 12 months.

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Wesfarmers. The Motley Fool Australia has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Consumer Staples & Discretionary Shares

A gambler at a casino bets a pile of chips on one number
Consumer Staples & Discretionary Shares

Own Star Entertainment shares? Here are the takeover details and when you'll get to vote

Star Entertainment has released details of the takeover deal with US casino giant Bally's.

Read more »

A happy investor sits at his desk in front of his laptop and does the mexican wave with his arms to celebrate the returns from his ASX dividend shares
Consumer Staples & Discretionary Shares

Guzman Y Gomez shares storm higher on very big news

Some big news has been released by this fast food company today.

Read more »

tick, approval, business person with device and tick of approval in background
Opinions

The Warren Buffett seal of approval: If the stock market closed for 10 years, I'd happily own this quality ASX 200 stock

I’d be happy to hold this ASX 200 stock for 10-plus years, in line with Warren Buffett’s advice.

Read more »

businesswoman holds hand out to shake
Consumer Staples & Discretionary Shares

Star Casino accepts $250 million takeover from new US owner

What does this mean for the casino operator?

Read more »

A man in a supermarket strikes an unlikely pose while pushing a trolley, lifting both legs sideways off the ground and looking mildly rattled with a wide-mouthed expression.
Consumer Staples & Discretionary Shares

Supermarket resilience: why were Coles and Woolworths shares up last week?

Not even a market selloff could stop these shares from charging higher.

Read more »

Woman chooses vegetables for dinner, smiling and looking at camera.
Share Market News

Which ASX 200 market sector GAINED value during last week's rout?

The Australian share market was in turmoil over US tariffs last week, but one sector outshone its peers.

Read more »

Displeased and shocked emotional young friends cooking in the kitchen.
Consumer Staples & Discretionary Shares

Breville shares fall 12% on US tariffs announcement

Breville shares are among the worst-hit ASX 200 stocks after the US announced a range of new tariffs.

Read more »

A man looking at his laptop and thinking.
Consumer Staples & Discretionary Shares

What now for Star Entertainment shares after $940M funding deal withdrawn

Negotiations between Star Entertainment and Salter Brothers Capital have ended.

Read more »